RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Spirox Stock

Spirox Revenue 2024

Spirox Revenue

1.23 B TWD

Ticker

3055.TW

ISIN

TW0003055000

In 2024, Spirox's sales reached 1.23 B TWD, a -8.32% difference from the 1.34 B TWD sales recorded in the previous year.

The Spirox Revenue history

YEARREVENUE (undefined TWD)GROSS MARGIN (%)
2025e1.318,41
2024e1.2319,37
20231.3417,76
20221.918,97
20212.6511,51
20202.0218,48
20192.9118,77
20183.1522,36
20172.6521,86
20163.5121,23
20152.9422,02
20143.4424,34
20132.7917,49
20123.3121,28
20113.421,05
20104.820,03
20092.7523,38
20083.9720,45
20077.1418,02
20067.0319,83
20057.7820,32
20049.3420,90

Spirox Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Spirox, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Spirox from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Spirox’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Spirox. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Spirox’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Spirox’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Spirox’s growth potential.

Spirox Revenue, EBIT and net profit per share

DateSpirox RevenueSpirox EBITSpirox Net Income
2025e1.3 B TWD-121.38 M TWD-99.66 M TWD
2024e1.23 B TWD-117.3 M TWD-190.15 M TWD
20231.34 B TWD-189.82 M TWD-56.09 M TWD
20221.91 B TWD-418.29 M TWD240.16 M TWD
20212.65 B TWD-356.63 M TWD-357.47 M TWD
20202.02 B TWD-178.18 M TWD-45.01 M TWD
20192.91 B TWD-46.53 M TWD10.17 M TWD
20183.15 B TWD67.98 M TWD86.17 M TWD
20172.65 B TWD52.74 M TWD38.69 M TWD
20163.51 B TWD170.81 M TWD138.54 M TWD
20152.94 B TWD81.53 M TWD602.29 M TWD
20143.44 B TWD292.8 M TWD287.26 M TWD
20132.79 B TWD-73.4 M TWD-503.4 M TWD
20123.31 B TWD54.7 M TWD63.6 M TWD
20113.4 B TWD117.2 M TWD99.5 M TWD
20104.8 B TWD314 M TWD359.9 M TWD
20092.75 B TWD106.7 M TWD203 M TWD
20083.97 B TWD76 M TWD208.2 M TWD
20077.14 B TWD555.7 M TWD780.8 M TWD
20067.03 B TWD555.7 M TWD568.6 M TWD
20057.78 B TWD698.1 M TWD634 M TWD
20049.34 B TWD1.07 B TWD765.2 M TWD

Spirox stock margins

The Spirox margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Spirox. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Spirox.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Spirox's sales revenue. A higher gross margin percentage indicates that the Spirox retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Spirox's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Spirox's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Spirox's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Spirox. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Spirox's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Spirox Margin History

Spirox Gross marginSpirox Profit marginSpirox EBIT marginSpirox Profit margin
2025e17.76 %-9.37 %-7.7 %
2024e17.76 %-9.53 %-15.45 %
202317.76 %-14.14 %-4.18 %
20228.97 %-21.85 %12.54 %
202111.51 %-13.48 %-13.51 %
202018.48 %-8.84 %-2.23 %
201918.77 %-1.6 %0.35 %
201822.36 %2.16 %2.73 %
201721.86 %1.99 %1.46 %
201621.23 %4.86 %3.94 %
201522.02 %2.78 %20.51 %
201424.34 %8.5 %8.34 %
201317.49 %-2.63 %-18.07 %
201221.28 %1.65 %1.92 %
201121.05 %3.45 %2.93 %
201020.03 %6.54 %7.5 %
200923.38 %3.88 %7.37 %
200820.45 %1.92 %5.25 %
200718.02 %7.78 %10.93 %
200619.83 %7.91 %8.09 %
200520.32 %8.97 %8.14 %
200420.9 %11.47 %8.19 %

Spirox Aktienanalyse

What does Spirox do?

The Spirox Corporation is a company that was founded in 2007 and is headquartered in Menlo Park, California. The company operates in the medical technology industry and specializes in the development of products for nasal breathing. The mission of Spirox is to help people who have difficulty breathing through their nose. The company has recognized that many people have difficulty breathing through their nose due to congestion or other issues. Breathing through the mouth, however, can lead to a range of health problems such as dry mouth, sleep apnea, and respiratory infections. Therefore, Spirox has set out to develop innovative solutions to facilitate nasal breathing. Spirox's products include both implantable and non-implantable solutions. The company has a small but effective product portfolio consisting of two products: the Latera Nasal Stent and the AeroForm Nasal Stent. The Latera Nasal Stent is used to permanently open the nasal passages and facilitate breathing. The placement of the stent is a minimally invasive procedure that is typically performed on an outpatient basis. The Latera Nasal Stent is inserted and secured in the nasal wings to allow for better airflow through the nostrils. The stent is made of polydioxanone (PDO), a biocompatible polymer fiber that is absorbed by the body. Spirox's second product, the AeroForm Nasal Stent, is a non-implantable nasal stent used for temporary relief of nasal breathing. The AeroForm is a soft stent made of a flexible polymer material. It is inserted into the nasal passages and forms a gentle expansion to facilitate nasal breathing. As a company, Spirox focuses on collaboration with specialists and clinics to ensure that their products have high success rates. The company has established a partnership with the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) to advance scientific research and development in the nasal breathing industry. Spirox is led by experienced executives from the medical technology industry. The CEO, Duke Rohlen, has over 20 years of experience in leading medical technology companies such as Inspire Medical Systems and CV Ingenuity. The board team also includes Elektra Papadopoulos as Chair of the Board, who has worked at Hologic and Boston Scientific, among others. Although Spirox is a relatively small company, it has already received several awards. In 2017, the company was awarded the Red Herring Top 100 North America Award, which recognizes companies that are leading in the innovation industry. Overall, Spirox is an emerging company in the medical technology industry that offers innovative solutions to facilitate nasal breathing. Through collaboration with doctors and clinics and a focus on scientific research, the company aims to improve the success and effectiveness of its products. Spirox ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Spirox's Sales Figures

The sales figures of Spirox originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Spirox’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Spirox's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Spirox’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Spirox stock

How much revenue did Spirox generate this year?

Spirox has achieved a revenue of 1.23 B TWD this year.

How much was the turnover of the company Spirox compared to the previous year?

The revenue of Spirox has increased by -8.32% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Spirox?

The revenue of Spirox is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Spirox measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Spirox so important for investors?

The revenue of Spirox is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Spirox pay?

Over the past 12 months, Spirox paid a dividend of 1 TWD . This corresponds to a dividend yield of about 1.48 %. For the coming 12 months, Spirox is expected to pay a dividend of 0.87 TWD.

What is the dividend yield of Spirox?

The current dividend yield of Spirox is 1.48 %.

When does Spirox pay dividends?

Spirox pays a quarterly dividend. This is distributed in the months of October, August, August, August.

How secure is the dividend of Spirox?

Spirox paid dividends every year for the past 0 years.

What is the dividend of Spirox?

For the upcoming 12 months, dividends amounting to 0.87 TWD are expected. This corresponds to a dividend yield of 1.29 %.

In which sector is Spirox located?

Spirox is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Spirox kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Spirox from 8/6/2024 amounting to 1.011 TWD, you needed to have the stock in your portfolio before the ex-date on 7/5/2024.

When did Spirox pay the last dividend?

The last dividend was paid out on 8/6/2024.

What was the dividend of Spirox in the year 2023?

In the year 2023, Spirox distributed 0.2 TWD as dividends.

In which currency does Spirox pay out the dividend?

The dividends of Spirox are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Spirox

Our stock analysis for Spirox Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spirox Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.